Genome-wide Association Study

Samsung Medical Center

Status: Withdrawn

Conditions: Esophageal Squamous Cell Carcinoma

Study type: Observational

Funder types: Other

Identifiers

NCT01498757

2011-05-076

Details and patient eligibility

About

To explore biomarkers predictive of clinical response to Taxane/5-FU/platinum based chemotherapy in esophageal squamous cell carcinoma. To identify negative predictive markers to 5-FU/platinum/Taxane. To elucidate signal transduction pathway attributable to 5-FU/platinum/Taxane resistance. To analyze correlation between the quantity of circulating tumor cells and circulating endothelial cell precursors and treatment response to Taxane/5-FU/platinum based chemotherapy.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Histological confirmed esophageal squamous cell carcinoma
• Patients treated with Taxane or 5-FU or platinum based chemotherapy.
• provision of a signed written informed consent.

Exclusion criteria

• patients not signed written informed consent.
• patient unacceptable for study in the judgement of the investigator.

Trial design

0 participants in 1 patient group

Patients treated with Taxane/5-FU/platinum based chemo.